{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:05:35Z","timestamp":1791104735088,"version":"4.1.0"},"reference-count":31,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Prostate cancer is a leading and increasingly prevalent cause of cancer death in men. Whereas family history of disease is one of the strongest prostate cancer risk factors and suggests a hereditary component, the predisposing genetic factors remain unknown. We first showed that KLF6 is a tumor suppressor somatically inactivated in prostate cancer and since then, its functional loss has been further established in prostate cancer cell lines and other human cancers. Wild-type KLF6, but not patient-derived mutants, suppresses cell growth through p53-independent transactivation of p21. Here we show that a germline KLF6 single nucleotide polymorphism, confirmed in a tri-institutional study of 3,411 men, is significantly associated with an increased relative risk of prostate cancer in men, regardless of family history of disease. This prostate cancer\u2013associated allele generates a novel functional SRp40 DNA binding site and increases transcription of three alternatively spliced KLF6 isoforms. The KLF6 variant proteins KLF6-SV1 and KLF6-SV2 are mislocalized to the cytoplasm, antagonize wtKLF6 function, leading to decreased p21 expression and increased cell growth, and are up-regulated in tumor versus normal prostatic tissue. Thus, these results are the first to identify a novel mechanism of self-encoded tumor suppressor gene inactivation and link a relatively common single nucleotide polymorphism to both regulation of alternative splicing and an increased risk in a major human cancer.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-4249","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T21:28:12Z","timestamp":1126819692000},"page":"1213-1222","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["A Germline DNA Polymorphism Enhances Alternative Splicing of the <i>KLF6<\/i> Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk"],"prefix":"10.1158","volume":"65","author":[{"given":"Goutham","family":"Narla","sequence":"first","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analisa","family":"DiFeo","sequence":"additional","affiliation":[{"name":"2Human Genetics, Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Reeves","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Schaid","sequence":"additional","affiliation":[{"name":"3Departments of Health Sciences Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hirshfeld","sequence":"additional","affiliation":[{"name":"2Human Genetics, Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad","family":"Hod","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Katz","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"5Brady Urological Institute, Johns Hopkins Medical Institution, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hebbring","sequence":"additional","affiliation":[{"name":"4Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Komiya","sequence":"additional","affiliation":[{"name":"5Brady Urological Institute, Johns Hopkins Medical Institution, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon K.","family":"McDonnell","sequence":"additional","affiliation":[{"name":"3Departments of Health Sciences Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Wiley","sequence":"additional","affiliation":[{"name":"5Brady Urological Institute, Johns Hopkins Medical Institution, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"3Departments of Health Sciences Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"5Brady Urological Institute, Johns Hopkins Medical Institution, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"Walsh","sequence":"additional","affiliation":[{"name":"5Brady Urological Institute, Johns Hopkins Medical Institution, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lilly","family":"Zheng","sequence":"additional","affiliation":[{"name":"10Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Li","family":"Chang","sequence":"additional","affiliation":[{"name":"10Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Friedrichsen","sequence":"additional","affiliation":[{"name":"6Divisions of Clinical Human Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Stanford","sequence":"additional","affiliation":[{"name":"7Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine A.","family":"Ostrander","sequence":"additional","affiliation":[{"name":"6Divisions of Clinical Human Biology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[{"name":"8Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[{"name":"10Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N.","family":"Thibodeau","sequence":"additional","affiliation":[{"name":"4Laboratory Medicine and Pathology, Mayo Clinic Foundation, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Martignetti","sequence":"additional","affiliation":[{"name":"2Human Genetics, Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"2022061621181586800_B1","doi-asserted-by":"crossref","unstructured":"Jemal ATA, Murray T, Thun M. Cancer statistics. CA Cancer J Clin\u20082002; 52: 23\u201347.","DOI":"10.3322\/canjclin.52.1.23"},{"key":"2022061621181586800_B2","doi-asserted-by":"crossref","unstructured":"Baselga J, Norton L. Focus on breast cancer. Cancer Cell\u20082002; 4: 319\u201322.","DOI":"10.1016\/S1535-6108(02)00066-1"},{"key":"2022061621181586800_B3","doi-asserted-by":"crossref","unstructured":"Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell\u20081996; 87: 159\u201370.","DOI":"10.1016\/S0092-8674(00)81333-1"},{"key":"2022061621181586800_B4","doi-asserted-by":"crossref","unstructured":"Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet\u20082000; 67: 1367\u201375.","DOI":"10.1086\/316916"},{"key":"2022061621181586800_B5","doi-asserted-by":"crossref","unstructured":"Tavtigian SV, Simard J, Teng DH, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet\u20082001; 27: 172\u201380.","DOI":"10.1038\/84808"},{"key":"2022061621181586800_B6","doi-asserted-by":"crossref","unstructured":"Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet\u20082002; 30: 181\u20134.","DOI":"10.1038\/ng823"},{"key":"2022061621181586800_B7","doi-asserted-by":"crossref","unstructured":"Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet\u20082002; 32: 321\u20135.","DOI":"10.1038\/ng994"},{"key":"2022061621181586800_B8","doi-asserted-by":"crossref","unstructured":"Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet\u20082004; 13: R103\u201321.","DOI":"10.1093\/hmg\/ddh072"},{"key":"2022061621181586800_B9","doi-asserted-by":"crossref","unstructured":"Narla G, Heath KE, Reeves HL, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science\u20082001; 294: 2563\u20136.","DOI":"10.1126\/science.1066326"},{"key":"2022061621181586800_B10","doi-asserted-by":"crossref","unstructured":"Chen C, Hyytinen ER, Sun X, et al. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol\u20082003; 162: 1349\u201354.","DOI":"10.1016\/S0002-9440(10)63930-2"},{"key":"2022061621181586800_B11","doi-asserted-by":"crossref","unstructured":"Reeves HL, Narla G, Ogunbiyi O, et al. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology\u20082004; 126: 1090\u2013103.","DOI":"10.1053\/j.gastro.2004.01.005"},{"key":"2022061621181586800_B12","doi-asserted-by":"crossref","unstructured":"Jeng YM, Hsu HC. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer\u20082003; 105: 625\u20139.","DOI":"10.1002\/ijc.11123"},{"key":"2022061621181586800_B13","unstructured":"Chen HK, Liu XQ, Lin J, Chen TY, Feng QS, Zeng YX. Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng\u20082002; 21: 1047\u201350."},{"key":"2022061621181586800_B14","doi-asserted-by":"crossref","unstructured":"Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell\u20082002; 2: 485\u201395.","DOI":"10.1016\/S1535-6108(02)00215-5"},{"key":"2022061621181586800_B15","doi-asserted-by":"crossref","unstructured":"Kettunen E, Anttila S, Seppanen JK, et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet\u20082004; 149: 98\u2013106.","DOI":"10.1016\/S0165-4608(03)00300-5"},{"key":"2022061621181586800_B16","doi-asserted-by":"crossref","unstructured":"Ito G, Uchiyama M, Kondo M, et al. Kruppel-Like Factor 6 (KLF6) is frequently downregulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res\u20082004; 11: 3838\u201343.","DOI":"10.1158\/0008-5472.CAN-04-0185"},{"key":"2022061621181586800_B17","doi-asserted-by":"crossref","unstructured":"Kimmelman AC, Qiao RF, Narla G, et al. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6. Oncogene\u20082004; 29: 5077\u201383.","DOI":"10.1038\/sj.onc.1207662"},{"key":"2022061621181586800_B18","doi-asserted-by":"crossref","unstructured":"Benzeno S, Narla G, Allina J, et al. Cyclin dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res\u20082004; 64: 3885\u201391.","DOI":"10.1158\/0008-5472.CAN-03-2818"},{"key":"2022061621181586800_B19","doi-asserted-by":"crossref","unstructured":"Slavin DA, Koritschoner NP, Prieto CC, Lopez-Diaz FJ, Chatton B, Bocco JL. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function. Oncogene\u20082004; 23: 8196\u2013205.","DOI":"10.1038\/sj.onc.1208020"},{"key":"2022061621181586800_B20","doi-asserted-by":"crossref","unstructured":"Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest\u20082004; 113: 913\u201323.","DOI":"10.1172\/JCI20032"},{"key":"2022061621181586800_B21","doi-asserted-by":"crossref","unstructured":"Carpten J, Nupponen N, Isaacs S, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet\u20082002; 30: 181\u20134.","DOI":"10.1038\/ng823"},{"key":"2022061621181586800_B22","unstructured":"Wang L, McDonnell SK, Elkins DA, et al. Role of HPC2\/ELAC2 in hereditary prostate cancer. Cancer Res\u20082001; 61: 6494\u20139."},{"key":"2022061621181586800_B23","unstructured":"Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev\u20081999; 8: 881\u20136."},{"key":"2022061621181586800_B24","doi-asserted-by":"crossref","unstructured":"Slager S, Schaid D. Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet\u20082001; 68: 1457\u201362.","DOI":"10.1086\/320608"},{"key":"2022061621181586800_B25","unstructured":"Weir BS. Genetic Data Analysis II. Methods for discrete population genetic data. Massachusetts: Sinaur Associates, Inc.; 1996."},{"key":"2022061621181586800_B26","doi-asserted-by":"crossref","unstructured":"Sasieni P. From genotypes to genes: doubling the sample size. Biometrics\u20081997; 53: 1253\u201361.","DOI":"10.2307\/2533494"},{"key":"2022061621181586800_B27","doi-asserted-by":"crossref","unstructured":"Liu HX, Zhang M, Krainer AR. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev\u20081998; 12: 1998\u20132012.","DOI":"10.1101\/gad.12.13.1998"},{"key":"2022061621181586800_B28","doi-asserted-by":"crossref","unstructured":"Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science\u20082002; 296: 550\u20133.","DOI":"10.1126\/science.1068999"},{"key":"2022061621181586800_B29","doi-asserted-by":"crossref","unstructured":"Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature\u20082001; 412: 822\u20136.","DOI":"10.1038\/35090585"},{"key":"2022061621181586800_B30","doi-asserted-by":"crossref","unstructured":"Quadrini KJ, Bieker JJ. Kruppel-like zinc fingers bind to nuclear import proteins and are required for efficient nuclear localization of erythroid Kruppel-like factor. J Biol Chem\u20082002; 277: 32243\u201352.","DOI":"10.1074\/jbc.M205677200"},{"key":"2022061621181586800_B31","doi-asserted-by":"crossref","unstructured":"Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res\u20082003; 31: 3568\u201371.","DOI":"10.1093\/nar\/gkg616"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/4\/1213\/2540097\/1213-1222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/4\/1213\/2540097\/1213-1222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:11:09Z","timestamp":1655421069000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/4\/1213\/518945\/A-Germline-DNA-Polymorphism-Enhances-Alternative"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,15]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,2,25]]},"published-print":{"date-parts":[[2005,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-4249","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,15]]}}}